References
- Conte MS, Bradbury AW, Kolh P, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S–125S.e40. doi: 10.1016/j.jvs.2019.02.016
- Aboyans V, Ricco JB, Bartelink MLEL, et al. Editor’s Choice – 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). European Journal of Vascular and Endovascular Surgery. 2018;55(3):305–368. doi: 10.1016/j.ejvs.2017.07.018
- Fontaine R, Kim M, Kieny R. [Surgical treatment of peripheral circulation disorders]. Helv Chir Acta. 1954;21(5–6):499–533.
- Baubeta Fridh E, Andersson M, Thuresson M, et al. Amputation Rates, Mortality, and Pre-operative Comorbidities in Patients Revascularised for Intermittent Claudication or Critical Limb Ischaemia: A Population Based Study. Eur J Vasc Endovasc Surg. 2017;54(4):480–486. doi: 10.1016/j.ejvs.2017.07.005
- Signorelli SS, Anzaldi M, Libra M, et al. Plasma Levels of Inflammatory Biomarkers in Peripheral Arterial Disease: Results of a Cohort Study. Angiology. 2016;67(9):870–874. doi: 10.1177/0003319716633339
- Igari K, Kudo T, Toyofuku T, Inoue Y. Relationship of Inflammatory Biomarkers with Severity of Peripheral Arterial Disease. Int J Vasc Med. 2016;2016:6015701. doi: 10.1155/2016/6015701
- Onofrei V, Crișan A, Adam CA, et al. The Role Played by Novel Inflammatory Markers in Assessment of Peripheral Artery Disease. Medicina. 2023;59(9):1557. doi: 10.3390/medicina59091557
- Kaller R, Russu E, Arbănași EM, et al. Intimal CD31-Positive Relative Surfaces Are Associated with Systemic Inflammatory Markers and Maturation of Arteriovenous Fistula in Dialysis Patients. Journal of Clinical Medicine. 2023;12(13):4419. doi: 10.3390/jcm12134419
- Niculescu R, Russu E, Arbănași EM, et al. Carotid Plaque Features and Inflammatory Biomarkers as Predictors of Restenosis and Mortality Following Carotid Endarterectomy. International Journal of Environmental Research and Public Health. 2022;19(21):13934. doi: 10.3390/ijerph192113934
- Kaller R, Arbănași EM, Mureșan AV, et al. The Predictive Value of Systemic Inflammatory Markers, the Prognostic Nutritional Index, and Measured Vessels’ Diameters in Arteriovenous Fistula Maturation Failure. Life. 2022;12(9):1447. doi: 10.3390/life12091447
- Arbănași EM, Mureșan AV, Coșarcă CM, et al. Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Impact on Predicting Outcomes in Patients with Acute Limb Ischemia. Life. 2022;12(6):822. doi: 10.3390/life12060822
- Russu E, Mureșan AV, Arbănași EM, et al. The Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease. Journal of Clinical Medicine. 2022;11(9):2620. doi: 10.3390/jcm11092620
- Arbănași EM, Mureșan AV, Arbănași EM, et al. The Neutrophil-to-Lymphocyte Ratio’s Predictive Utility in Acute Pulmonary Embolism: Systematic Review. Journal Of Cardiovascular Emergencies. 2022;8(2):25–30. doi: 10.2478/jce-2022-0005
- Lăpădatu BI, Russu E. Neutrophil-to-Lymphocyte Ratio – Risk of Amputation and Mortality in Patients with Limb-Threatening Ischemia – a Systematic Review. Journal of Cardiovascular Emergencies. 2024;10(1):7–12. doi: 10.2478/jce-2024-0006
- Mureșan AV, Hălmaciu I, Arbănași EM, et al. Prognostic Nutritional Index, Controlling Nutritional Status (CONUT) Score, and Inflammatory Biomarkers as Predictors of Deep Vein Thrombosis, Acute Pulmonary Embolism, and Mortality in COVID-19 Patients. Diagnostics. 2022;12(11):2757. doi: 10.3390/diagnostics12112757
- Arbănași EM, Halmaciu I, Kaller R, et al. Systemic Inflammatory Biomarkers and Chest CT Findings as Predictors of Acute Limb Ischemia Risk, Intensive Care Unit Admission, and Mortality in COVID-19 Patients. Diagnostics. 2022;12(10):2379. doi: 10.3390/diagnostics12102379
- Halmaciu I, Arbănași EM, Kaller R, et al. Chest CT Severity Score and Systemic Inflammatory Biomarkers as Predictors of the Need for Invasive Mechanical Ventilation and of COVID-19 Patients’ Mortality. Diagnostics. 2022;12(9):2089. doi: 10.3390/diagnostics12092089
- Russu E, Arbănaşi EM, Șchiopu A. Special Issue “COVID-19 Coagulopathy: Advances on Pathophysiology and Therapies.” International Journal of Molecular Sciences. 2024;25(6):3548. doi: 10.3390/ijms25063548
- Stoian M, Andone A, Boeriu A, et al. COVID-19 and Clostridioides difficile Coinfection Analysis in the Intensive Care Unit. Antibiotics. 2024;13(4):367. doi: 10.3390/antibiotics13040367
- Stoian A, Bajko Z, Stoian M, et al. The Occurrence of Acute Disseminated Encephalomyelitis in SARS-CoV-2 Infection/Vaccination: Our Experience and a Systematic Review of the Literature. Vaccines. 2023;11(7):1225. doi: 10.3390/vaccines11071225
- Hogea T, Suciu BA, Chinezu L, et al. Pregnancy-Associated Spontaneous Coronary Acute Dissection as a Cause of Sudden Cardiac Death—Autopsy Findings and Literature Review: Is COVID-19 Related? Medicina. 2023;59(7):1257. doi: 10.3390/medicina59071257
- Arbănași EM, Kaller R, Mureșan AV, Voidăzan S, Arbanasi EM, Russu E. Impact of COVID-19 pandemic on Vascular Surgery Unit activity in Central Romania. Front Surg. 2022;9:883935. doi: 10.3389/fsurg.2022.883935
- Mureșan AV, Russu E, Arbănași EM, et al. Negative Impact of the COVID-19 Pandemic on Kidney Disease Management—A Single-Center Experience in Romania. Journal of Clinical Medicine. 2022;11(9):2452. doi: 10.3390/jcm11092452
- Bui QT, Prempeh M, Wilensky RL. Atherosclerotic plaque development. Int J Biochem Cell Biol. 2009;41(11):2109–2113. doi: 10.1016/j.biocel.2009.06.002
- Sakakura K, Nakano M, Otsuka F, Ladich E, Kolodgie FD, Virmani R. Pathophysiology of atherosclerosis plaque progression. Heart Lung Circ. 2013;22(6):399–411. doi: 10.1016/j.hlc.2013.03.001
- Feldman CL, Stone PH. Intravascular hemodynamic factors responsible for progression of coronary atherosclerosis and development of vulnerable plaque. Curr Opin Cardiol. 2000;15(6):430–440. doi: 10.1097/00001573-200011000-00010
- Cicha I, Wörner A, Urschel K, et al. Carotid plaque vulnerability: a positive feedback between hemodynamic and biochemical mechanisms. Stroke. 2011;42(12):3502–3510. doi: 10.1161/STROKEAHA.111.627265
- Kazantsev AN, Korotkikh AV, Chernyavin MP, et al. Vertebral triangle of doctor A.N. Kazantsev - double vertebral artery in V3 segment. Radiol Case Rep. 2023;18(7):2370–2375. doi: 10.1016/j.radcr.2023.03.057
- De Nisco G, Hoogendoorn A, Chiastra C, et al. The impact of helical flow on coronary atherosclerotic plaque development. Atherosclerosis. 2020;300:39–46. doi: 10.1016/j.atherosclerosis.2020.01.027
- Liu Y, Luo X, Jia H, Yu B. The Effect of Blood Pressure Variability on Coronary Atherosclerosis Plaques. Front Cardiovasc Med. 2022;9:803810. doi: 10.3389/fcvm.2022.803810
- Hansson GK, Libby P, Tabas I. Inflammation and plaque vulnerability. J Intern Med. 2015;278(5):483–493. doi: 10.1111/joim.12406
- Zhu Y, Xian X, Wang Z, et al. Research Progress on the Relationship between Atherosclerosis and Inflammation. Biomolecules. 2018;8(3):80. doi: 10.3390/biom8030080
- Lutgens E, van Suylen RJ, Faber BC, et al. Atherosclerotic Plaque Rupture. Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23(12):2123–2130. doi: 10.1161/01.ATV.0000097783.01596.E2
- Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105(9):1135–1143. doi: 10.1161/hc0902.104353
- Barani J, Nilsson JA, Mattiasson I, Lindblad B, Gottsäter A. Inflammatory mediators are associated with 1-year mortality in critical limb ischemia. J Vasc Surg. 2005;42(1):75–80. doi: 10.1016/j.jvs.2005.03.025
- Gremmels H, Teraa M, de Jager SCA, Pasterkamp G, de Borst GJ, Verhaar MC. A Pro-Inflammatory Biomarker-Profile Predicts Amputation-Free Survival in Patients with Severe Limb Ischemia. Sci Rep. 2019;9(1):10740. doi: 10.1038/s41598-019-47217-1
- Flex A, Gaetani E, Angelini F, et al. Pro-inflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia. J Intern Med. 2007;262(1):124–130. doi: 10.1111/j.1365-2796.2007.01791.x
- Ferreira J, Carneiro A, Vila I, et al. Inflammation and Loss of Skeletal Muscle Mass in Chronic Limb Threatening Ischemia. Ann Vasc Surg. 2023;88:164–173. doi: 10.1016/j.avsg.2022.07.009
- Ferreira J, Afonso J, Longatto-Filho A, et al. Inflammation Is a Histological Characteristic of Skeletal Muscle in Chronic Limb Threatening Ischemia. Ann Vasc Surg. 2024;99:10–18. doi: 10.1016/j.avsg.2023.09.094
- Ferreira J, Roque S, Lima Carneiro A, et al. Reversion of the Inflammatory Markers in Patients With Chronic Limb-Threatening Ischemia. J Am Heart Assoc. 2024;13(8):e031922. doi: 10.1161/JAHA.123.031922
- Candemir M, Kiziltunç E, Nurkoç S, Şahinarslan A. Relationship Between Systemic Immune-Inflammation Index (SII) and the Severity of Stable Coronary Artery Disease. Angiology. 2021;72(6):575–581. doi: 10.1177/0003319720987743
- Mangalesh S, Dudani S, Mahesh NK. Development of a Novel Inflammatory Index to Predict Coronary Artery Disease Severity in Patients With Acute Coronary Syndrome. Angiology. 2024;75(3):231–239. doi: 10.1177/00033197231151564
- Yang YL, Wu CH, Hsu PF, et al. Systemic immune-inflammation index (SII) predicted clinical outcome in patients with coronary artery disease. Eur J Clin Invest. 2020;50(5):e13230. doi: 10.1111/eci.13230
- Oflar E, Akdeniz E, Yıldız C, et al. Evaluation of systemic immune-inflammation index for predicting severity of lower extremity arterial disease. Vascular. Published online May 5, 2024:17085381241251772. doi: 10.1177/17085381241251772
- Aktemur T, Demirci G, Tasbulak O, et al. A Simple Predictor for Long-Term Mortality After Percutaneous Iliac Artery Intervention: Systemic Immune Inflammatory Index. Ann Vasc Surg. 2023;96:276–283. doi: 10.1016/j.avsg.2023.03.012
- Wang P, Guo X, Zhou Y, et al. Monocyte-to-high-density lipoprotein ratio and systemic inflammation response index are associated with the risk of metabolic disorders and cardiovascular diseases in general rural population. Front Endocrinol (Lausanne). 2022;13:944991. doi: 10.3389/fendo.2022.944991
- Xia Y, Xia C, Wu L, Li Z, Li H, Zhang J. Systemic Immune Inflammation Index (SII), System Inflammation Response Index (SIRI) and Risk of All-Cause Mortality and Cardiovascular Mortality: A 20-Year Follow-Up Cohort Study of 42,875 US Adults. J Clin Med. 2023;12(3):1128. doi: 10.3390/jcm12031128
- Dziedzic EA, Gąsior JS, Tuzimek A, et al. Investigation of the Associations of Novel Inflammatory Biomarkers-Systemic Inflammatory Index (SII) and Systemic Inflammatory Response Index (SIRI)-With the Severity of Coronary Artery Disease and Acute Coronary Syndrome Occurrence. Int J Mol Sci. 2022;23(17):9553. doi: 10.3390/ijms23179553
- Li Y, Bai G, Gao Y, et al. The Systemic Immune Inflammatory Response Index Can Predict the Clinical Prognosis of Patients with Initially Diagnosed Coronary Artery Disease. Journal of Inflammation Research. 2023;16:5069. doi: 10.2147/JIR.S432506
- Liu Y, Liu J, Liu L, et al. Association of Systemic Inflammatory Response Index and Pan-Immune-Inflammation-Value with Long-Term Adverse Cardiovascular Events in ST-Segment Elevation Myocardial Infarction Patients After Primary Percutaneous Coronary Intervention. J Inflamm Res. 2023;16:3437–3454. doi: 10.2147/JIR.S421491
- Han K, Shi D, Yang L, et al. Prognostic value of systemic inflammatory response index in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Ann Med. 2022;54(1):1667–1677. doi: 10.1080/07853890.2022.2083671